{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:48:05Z","timestamp":1782190085733,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10099-w","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:39:10Z","timestamp":1773909550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of 5-fluorouracil and metronomic chemotherapy mediated ornithine decarboxylase antizyme for inhibiting of colorectal cancer"],"prefix":"10.1007","volume":"58","author":[{"given":"Qingwei","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"2","key":"10099_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/medsci6020048","volume":"6","author":"L Abaandou","year":"2018","unstructured":"Abaandou L and Shiloach J (2018) Knocking out ornithine decarboxylase antizyme 1 (OAZ1) improves Recombinant protein expression in the HEK293 cell line. Med Sci (Basel) 6(2):48. https:\/\/doi.org\/10.3390\/medsci6020048","journal-title":"Med Sci (Basel)"},{"key":"10099_CR2","doi-asserted-by":"publisher","unstructured":"Baris MM, Serinan E, Calisir M, Simsek K, Aktas S, Yilmaz O, Ozdemir SK., and Secil M (2020) Xenograft tumor volume measurement in nude mice: estimation of 3d ultrasound volume measurements based on manual caliper measurements. DokuzEyulUniversitesiSaglikBilimleri Enstitusu, 2020(2). https:\/\/doi.org\/10.30621\/JBACHS.2020.902","DOI":"10.30621\/JBACHS.2020.902"},{"key":"10099_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-1-4939-6625-7_22","volume":"1527","author":"AN Cat","year":"2017","unstructured":"Cat AN, Briones AM (2017) Isolation of mature adipocytes from white adipose tissue and gene expression studies by real-time quantitative RT-PCR. Methods Mol Biol 1527:283\u2013295. https:\/\/doi.org\/10.1007\/978-1-4939-6625-7_22","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10099_CR4","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1038\/s41467-020-19173-2","volume":"11","author":"YH Cho","year":"2020","unstructured":"Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, Kim I, Clevers T, Choi H, K.Y (2020) 5-FU promotes stemness of colorectal cancer via p53-mediated WNT\/\u03b2-catenin pathway activation. Nat Commun 11(1):5321. https:\/\/doi.org\/10.1038\/s41467-020-19173-2","journal-title":"Nat Commun"},{"issue":"10207","key":"10099_CR5","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal Cancer Lancet 394(10207):1467\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0","journal-title":"Colorectal Cancer Lancet"},{"issue":"4","key":"10099_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10637-018-0579-8","volume":"36","author":"T Di Desidero","year":"2018","unstructured":"Di Desidero T, Orlandi P, Fioravanti A, Cremolini C, Loupakis F, Marmorino F, Antoniotti C, Masi G, Lonardi S, Bergamo F, Zagonel V, Falcone A, Bocci G (2018) Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients. Invest New Drugs 36(4):709\u2013714. https:\/\/doi.org\/10.1007\/s10637-018-0579-8","journal-title":"Invest New Drugs"},{"issue":"13","key":"10099_CR7","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS (2022) Ribosome biogenesis: A central player in cancer metastasis and therapeutic resistance. Cancer Res 82(13):2344\u20132353. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4087","journal-title":"Cancer Res"},{"key":"10099_CR8","doi-asserted-by":"publisher","first-page":"102066","DOI":"10.1016\/j.ctrv.2020.102066","volume":"89","author":"JE Fares","year":"2020","unstructured":"Fares JE, El Tomb P, Khalil LE, Atwani RW, Moukadem HA, Awada A, Saghir E, N.S (2020) Metronomic chemotherapy for patients with metastatic breast cancer: review of effectiveness and potential use during pandemics. Cancer Treat Rev 89:102066. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102066","journal-title":"Cancer Treat Rev"},{"issue":"13","key":"10099_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1080\/14656566.2018.1512585","volume":"19","author":"R Filippi","year":"2018","unstructured":"Filippi R, Lombardi P, Depetris I, Fenocchio E, Quar\u00e0 V, Chil\u00e0 G, Aglietta M, Leone F (2018) Rationale for the use of metronomic chemotherapy in Gastrointestinal cancer. Expert Opin Pharmacother 19(13):1451\u20131463. https:\/\/doi.org\/10.1080\/14656566.2018.1512585","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"10099_CR10","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1016\/j.apsb.2024.06.028","volume":"14","author":"W Fu","year":"2024","unstructured":"Fu W, Lin Y, Bai M, Yao J, Huang C, Gao L, Mi N, Ma H, Tian L, Yue P, Zhang Y, Zhang J, Ren Y, Ding L, Dai L, Leung JW, Yuan J, Zhang W, Meng W (2024) Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing. Acta Pharm Sinica B 14(9):3931\u20133948. https:\/\/doi.org\/10.1016\/j.apsb.2024.06.028","journal-title":"Acta Pharm Sinica B"},{"issue":"11","key":"10099_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/genes8110295","volume":"8","author":"J Ge","year":"2017","unstructured":"Ge J, Karijolich J, Zhai Y, Zheng J, Yu YT (2017) 5-Fluorouracil treatment alters the efficiency of translational recoding. Genes (Basel) 8(11):295. https:\/\/doi.org\/10.3390\/genes8110295","journal-title":"Genes (Basel)"},{"issue":"2","key":"10099_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.20517\/cdr.2022.136","volume":"6","author":"WH Gmeiner","year":"2023","unstructured":"Gmeiner WH, Okechukwu CC (2023) Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. Cancer Drug Resist 6(2):257\u2013272. https:\/\/doi.org\/10.20517\/cdr.2022.136","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"10099_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/cancers11010083","volume":"11","author":"LG Guti\u00e9rrez","year":"2019","unstructured":"Guti\u00e9rrez LG, Hern\u00e1ndez-Morales M, N\u00fa\u00f1ez L, Villalobos C (2019) Inhibition of polyamine biosynthesis reverses Ca channel remodeling in colon Cancer cells. Cancers (Basel) 11(1):83. https:\/\/doi.org\/10.3390\/cancers11010083","journal-title":"Cancers (Basel)"},{"key":"10099_CR14","doi-asserted-by":"publisher","unstructured":"Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, andMassagu\u00e9 J (2000) OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell, 100(2):229\u2009\u2013\u200940. https:\/\/doi.org\/10.1016\/s0092-8674(00)81561-5","DOI":"10.1016\/s0092-8674(00)81561-5"},{"key":"10099_CR15","doi-asserted-by":"publisher","first-page":"878639","DOI":"10.3389\/fonc.2022.878639","volume":"12","author":"XC Hong","year":"2022","unstructured":"Hong XC, Liang QL, Chen M, Yang HX, Huang J, Yi SL, Wang ZW, Liang HY, Zhang DY, Huang ZY (2022) PRL-3 and MMP9 expression and Epithelial-Mesenchymal transition markers in Circulating tumor cells from patients with colorectal cancer: potential value in clinical practice. Front Oncol 12:878639. https:\/\/doi.org\/10.3389\/fonc.2022.878639","journal-title":"Front Oncol"},{"issue":"3","key":"10099_CR17","doi-asserted-by":"publisher","first-page":"e0174280","DOI":"10.1371\/journal.pone.0174280","volume":"12","author":"WY Huang","year":"2017","unstructured":"Huang WY, Ho CL, Lee CC, Hsiao CW, Wu CC, Jao SW, Yang JF, Lo CH, Chen JH (2017) Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer. PLoS ONE 12(3):e0174280. https:\/\/doi.org\/10.1371\/journal.pone.0174280","journal-title":"PLoS ONE"},{"issue":"11","key":"10099_CR16","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.3390\/nu12113575","volume":"12","author":"CY Huang","year":"2020","unstructured":"Huang CY, Fang YJ, Abulimiti A, Yang X, Li L, Liu KY, Zhang X, Feng XL, Chen YM, Zhang CX (2020) Dietary polyamines intake and risk of colorectal cancer: a case-control study. Nutrients 12(11):3575. https:\/\/doi.org\/10.3390\/nu12113575","journal-title":"Nutrients"},{"issue":"11","key":"10099_CR18","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jtho.2016.06.001","volume":"11","author":"JS Jang","year":"2016","unstructured":"Jang JS, Wang X, Vedell PT, Wen J, Zhang J, Ellison DW, Evans JM, Johnson SH, Yang P, Sukov WR, Oliveira AM, Vasmatzis G, Sun Z, Jen J, Yi ES (2016) Custom gene capture and next-generation sequencing to resolve discordant ALK status by FISH and IHC in lung adenocarcinoma. J Thorac Oncol 11(11):1891\u20131900. https:\/\/doi.org\/10.1016\/j.jtho.2016.06.001","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10099_CR19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3904\/kjim.2015.049","volume":"32","author":"YH Jung","year":"2017","unstructured":"Jung YH, Lee WJ, Byeon JH, Lee IK, Han CW, Woo IS (2017) Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients. Korean J Intern Med 32(5):926\u2013929. https:\/\/doi.org\/10.3904\/kjim.2015.049","journal-title":"Korean J Intern Med"},{"issue":"24","key":"10099_CR20","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1042\/BCJ20160519C","volume":"473","author":"C Kahana","year":"2016","unstructured":"Kahana C (2016) Protein degradation, the main hub in the regulation of cellular polyamines. Biochem J 473(24):4551\u20134558. https:\/\/doi.org\/10.1042\/BCJ20160519C","journal-title":"Biochem J"},{"issue":"2","key":"10099_CR21","doi-asserted-by":"publisher","first-page":"e0211564","DOI":"10.1371\/journal.pone.0211564","volume":"14","author":"T Kaprio","year":"2019","unstructured":"Kaprio T, Rasila T, Hagstr\u00f6m J, Mustonen H, Lankila P, Haglund C, Andersson LC (2019) Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer. PLoS ONE 14(2):e0211564. https:\/\/doi.org\/10.1371\/journal.pone.0211564","journal-title":"PLoS ONE"},{"issue":"2","key":"10099_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000526827","volume":"68","author":"AW Khatib","year":"2023","unstructured":"Khatib AW, Selub SM, Uryvaey A, Baranseh J, Shai A (2023) Initiating treatment with low fluorouracil dose and titrating according to blood levels in patients treated with a 46-Hour continuous infusion. Chemotherapy 68(2):95\u2013101. https:\/\/doi.org\/10.1159\/000526827","journal-title":"Chemotherapy"},{"issue":"8","key":"10099_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/10255842.2021.1985476","volume":"25","author":"A Kumar","year":"2022","unstructured":"Kumar A, Sinha N, Bhardwaj A, Goel S (2022) Clinical risk assessment of chronic kidney disease patients using genetic programming. Comput Methods Biomech Biomed Engin 25(8):887\u2013895. https:\/\/doi.org\/10.1080\/10255842.2021.1985476","journal-title":"Comput Methods Biomech Biomed Engin"},{"issue":"6","key":"10099_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1067\/j.cpradiol.2018.07.016","volume":"48","author":"UR Lalchandani","year":"2019","unstructured":"Lalchandani UR, Sahai V, Hersberger K, Francis IR, Wasnik AP (2019) A radiologist\u2019s guide to response evaluation criteria in solid tumors. Curr Probl Diagn Radiol 48(6):576\u2013585. https:\/\/doi.org\/10.1067\/j.cpradiol.2018.07.016","journal-title":"Curr Probl Diagn Radiol"},{"issue":"12","key":"10099_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/metabo10120487","volume":"10","author":"YR Lee","year":"2020","unstructured":"Lee YR, An KY, Jeon J, Kim NK, Lee JW, Hong J, Chung BC (2020) Untargeted metabolomics and polyamine profiling in serum before and after surgery in colorectal cancer patients. Metabolites 10(12):487. https:\/\/doi.org\/10.3390\/metabo10120487","journal-title":"Metabolites"},{"issue":"9","key":"10099_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1631\/jzus.B0920077","volume":"10","author":"QL Liang","year":"2009","unstructured":"Liang QL, Wang BR, Li GH (2009) DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters. J Zhejiang Univ Sci B 10(9):675\u2013682. https:\/\/doi.org\/10.1631\/jzus.B0920077","journal-title":"J Zhejiang Univ Sci B"},{"issue":"2","key":"10099_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/1878-0261.12417","volume":"13","author":"G Mauri","year":"2019","unstructured":"Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S (2019) Early-onset colorectal cancer in young individuals. Mol Oncol 13(2):109\u2013131. https:\/\/doi.org\/10.1002\/1878-0261.12417","journal-title":"Mol Oncol"},{"issue":"15","key":"10099_CR28","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","volume":"24","author":"RM McQuade","year":"2017","unstructured":"McQuade RM, Stojanovska V, Bornstein JC, andNurgali K (2017) Colorectal cancer chemotherapy: the evolution of treatment and new approaches. Curr Med Chem 24(15):1537\u20131557. https:\/\/doi.org\/10.2174\/0929867324666170111152436","journal-title":"Curr Med Chem"},{"issue":"11","key":"10099_CR29","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/14789450.2017.1388167","volume":"14","author":"M Mishra","year":"2017","unstructured":"Mishra M, Tiwari S, Gomes AV (2017) Protein purification and analysis: next generation Western blotting techniques. Expert Rev Proteom 14(11):1037\u20131053. https:\/\/doi.org\/10.1080\/14789450.2017.1388167","journal-title":"Expert Rev Proteom"},{"key":"10099_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.20517\/cdr.2025.76","volume":"8","author":"CC Okechukwu","year":"2025","unstructured":"Okechukwu CC, Gmeiner WH (2025) CF10\/LV overcomes acquired resistance to 5-FU\/LV in colorectal cancer cells through downregulation of the c-Myc\/ABCB5 axis. Cancer Drug Resist 8:35. https:\/\/doi.org\/10.20517\/cdr.2025.76","journal-title":"Cancer Drug Resist"},{"key":"10099_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-1-4939-7398-9_26","volume":"1694","author":"R Palanimurugan","year":"2018","unstructured":"Palanimurugan R, G\u00f6dderz D, Kurian L, Dohmen RJ (2018) Analysis of cotranslational polyamine sensing during decoding of ODC antizyme mRNA. Methods Mol Biol 1694:309\u2013323. https:\/\/doi.org\/10.1007\/978-1-4939-7398-9_26","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10099_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/medsci6040089","volume":"6","author":"B Ramos-Molina","year":"2018","unstructured":"Ramos-Molina B, Lambertos A, andPe\u00f1afiel R (2018) Antizyme inhibitors in polyamine metabolism and beyond: physiopathological implications. Med Sci (Basel) 6(4):89. https:\/\/doi.org\/10.3390\/medsci6040089","journal-title":"Med Sci (Basel)"},{"issue":"11","key":"10099_CR33","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.3390\/cancers12113084","volume":"12","author":"M Roberto","year":"2020","unstructured":"Roberto M, Romiti A, Mazzuca F, Milano A, D\u2019Antonio C, Lionetto L, Falcone R, Strigari L, Simmaco M, Fais S, Marchetti P (2020) Combination therapy of high-dose Rabeprazole plus metronomic capecitabine in advanced gastro-intestinal cancer: a randomized phase II trial. Cancers (Basel) 12(11):3084. https:\/\/doi.org\/10.3390\/cancers12113084","journal-title":"Cancers (Basel)"},{"key":"10099_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jpba.2017.05.006","volume":"147","author":"PK Sahu","year":"2018","unstructured":"Sahu PK, Ramisetti NR, Cecchi T, Swain S, Patro CS, Panda J (2018) An overview of experimental designs in HPLC method development and validation. J Pharm Biomed Anal 147:590\u2013611. https:\/\/doi.org\/10.1016\/j.jpba.2017.05.006","journal-title":"J Pharm Biomed Anal"},{"issue":"17","key":"10099_CR35","doi-asserted-by":"publisher","first-page":"9549","DOI":"10.3390\/ijms22179549","volume":"22","author":"L S\u00e1nchez-Alcoholado","year":"2021","unstructured":"S\u00e1nchez-Alcoholado L, Laborda-Illanes A, Otero A, Ord\u00f3\u00f1ez R, Gonz\u00e1lez-Gonz\u00e1lez A, Plaza-Andrades I, Ramos-Molina B, G\u00f3mez-Mill\u00e1n J, Queipo-Ortu\u00f1o MI (2021) Relationships of gut microbiota composition, short-chain fatty acids and polyamines with the pathological response to neoadjuvant radiochemotherapy in colorectal cancer patients. Int J Mol Sci 22(17):9549. https:\/\/doi.org\/10.3390\/ijms22179549","journal-title":"Int J Mol Sci"},{"key":"10099_CR36","doi-asserted-by":"publisher","first-page":"998274","DOI":"10.3389\/fonc.2022.998274","volume":"12","author":"A Scagliotti","year":"2022","unstructured":"Scagliotti A, Capizzi L, Cazzaniga ME, Ilari A, De Giorgi M, Cordani N, Gallazzi M, Bruno A, Pelosi G, Albini A, Lavitrano M, Grassilli E, Cerrito MG (2022) Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK\/VEGFR2\/VEGF axis and autophagy\/apoptosis activation. Front Oncol 12:998274. https:\/\/doi.org\/10.3389\/fonc.2022.998274","journal-title":"Front Oncol"},{"issue":"4","key":"10099_CR37","doi-asserted-by":"publisher","first-page":"BSR20170163","DOI":"10.1042\/BSR20170163","volume":"37","author":"KM Silander","year":"2017","unstructured":"Silander KM, Pihlajamaa P, Sahu B, J\u00e4nne OA, Andersson LC (2017) Characterization of an androgen-responsive, ornithine decarboxylase-related protein in mouse kidney. Biosci Rep 37(4):BSR20170163. https:\/\/doi.org\/10.1042\/BSR20170163","journal-title":"Biosci Rep"},{"key":"10099_CR38","doi-asserted-by":"publisher","unstructured":"Simsek C, Esin E, Yalcin S (2019) Metronomic chemotherapy: a systematic review of the literature and clinical experience. J. Oncol 2019:5483791. https:\/\/doi.org\/10.1155\/2019\/5483791","DOI":"10.1155\/2019\/5483791"},{"key":"10099_CR39","doi-asserted-by":"publisher","unstructured":"Sulzbacher MM, Sulzbacher LM, Passos FR, Bilibio BLE, de Oliveira K, Althaus WF, Frizzo MN, Ludwig MS, Cruz D, I. B. M. and, Heck TG (2022) Adapted Murine Sepsis Score: Improving the Research in Experimental Sepsis Mouse Model. Biomed Res Int 2022:5700853. https:\/\/doi.org\/10.1155\/2022\/5700853","DOI":"10.1155\/2022\/5700853"},{"key":"10099_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/OTT.S281157","volume":"14","author":"V Tulluri","year":"2021","unstructured":"Tulluri V and Nemmara VV (2021) Role of antizyme inhibitor proteins in cancers and beyond. Onco Targets Ther 14:667\u2013682. https:\/\/doi.org\/10.2147\/OTT.S281157","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10099_CR43","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41598-018-38017-0","volume":"9","author":"V Varghese","year":"2019","unstructured":"Varghese V, Magnani L, Harada-Shoji N, Mauri F, Szydlo RM, Yao S, Lam EW, Kenny LM (2019) FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. Sci Rep 9(1):1505. https:\/\/doi.org\/10.1038\/s41598-018-38017-0","journal-title":"Sci Rep"},{"key":"10099_CR44","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Ther 206:107447. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107447","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10099_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000353406","volume":"131","author":"B Wu","year":"2014","unstructured":"Wu B, Wang X, Ma W, Zheng W, Jiang L (2014) Assay of OAZ1 mRNA levels in chronic myeloid leukemia combined with application of leukemia PCR array identified relevant gene changes affected by antizyme. Acta Haematol 131(3):141\u2013147. https:\/\/doi.org\/10.1159\/000353406","journal-title":"Acta Haematol"},{"issue":"9","key":"10099_CR46","doi-asserted-by":"publisher","first-page":"e12554","DOI":"10.1371\/journal.pone.0012554","volume":"5","author":"D Yamamoto","year":"2010","unstructured":"Yamamoto D, Shima K, Matsuo K, Nishioka T, Chen CY, Hu GF, Sasaki A, Tsuji T (2010) Ornithine decarboxylase antizyme induces hypomethylation of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2) in human oral cancer cell line. PLoS ONE 5(9):e12554. https:\/\/doi.org\/10.1371\/journal.pone.0012554","journal-title":"PLoS ONE"},{"issue":"6","key":"10099_CR47","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/10826068.2020.1843177","volume":"51","author":"JB Zafer","year":"2021","unstructured":"Zafer JB, Dede S, Karaku\u015f E (2021) \u03b1-Amylase assay with starch-iodine-sodium fluorescein-based fluorometric method in human serum samples. Prep Biochem Biotechnol 51(6):599\u2013606. https:\/\/doi.org\/10.1080\/10826068.2020.1843177","journal-title":"Prep Biochem Biotechnol"},{"issue":"2","key":"10099_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.canlet.2016.08.004","volume":"381","author":"X Zhang","year":"2016","unstructured":"Zhang X, Chen Y, Hao L, Hou A, Chen X, Li Y, Wang R, Luo P, Ruan Z, Ou J, Shi C, Miao H, Liang H (2016) Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of Putrescine. Cancer Lett 381(2):305\u2013313. https:\/\/doi.org\/10.1016\/j.canlet.2016.08.004","journal-title":"Cancer Lett"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10099-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:12:00Z","timestamp":1782187920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-026-10099-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10099"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10099-w","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Second Affiliated Hospital of Naval Medical University Animal Research Ethics Committee (Ethical No.: 20200223). The experimental procedures were conducted following the National Institutes of Health (NIH) Guidelines for the Protection and Use of Laboratory Animals (NIH Publication No., as per regulations 85\u2009\u2212\u200923, updated in 1996. All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}